GLP-1 receptor agonist toxicity

Background

  • GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
    • Semaglutide
    • Liraglutide
  • Poison control centers have reported increasing inquiries related to possible overdoses

Clinical Features

Differential Diagnosis

Evaluation

Workup

Diagnosis

Management

  • Symptomatic management
    • Anti-nausa medications (e.g., zofran)
  • Consider stopping other glucose-lowering (i.e, diabetic) medications

Disposition

See Also

External Links

References